A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency

Allergy and Clinical Immunology Associates, Pittsburgh

Institute for Asthma and Allergy, Chevy Chase

Allergy & Asthma Clinics of Georgia, P.C., Albany

Allergy Associates of The Palm Beaches, North Palm Beach

Clinical Research Center of Alabama, Birmingham

Optimed Research LTD, Columbus

Washington University School of Medicine, St Louis

Allergy, Asthma and Clinical Research Center, Oklahoma City

Oklahoma Institute of Allergy and Asthma Clinical Research, Oklahoma City

Vital Prospect Clinical Research Institute, Tulsa

AARA Research Center, Dallas

Research Solutions of Arizona, PC, Litchfield Park